These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term followup of all patients with muscle invasive (stages T2, T3 and T4) bladder carcinoma in a geographical region. Holmäng S; Hedelin H; Anderström C; Johansson SL J Urol; 1997 Aug; 158(2):389-92. PubMed ID: 9224309 [TBL] [Abstract][Full Text] [Related]
4. [Therapy and follow-up of bladder cancer]. Meyer D; Schmid HP; Engeler DS Wien Med Wochenschr; 2007; 157(7-8):162-9. PubMed ID: 17492413 [TBL] [Abstract][Full Text] [Related]
5. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience. Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376 [TBL] [Abstract][Full Text] [Related]
6. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients. van Onna IE; Oddens JR; Kok ET; van Moorselaar RJ; Bosch JL; Battermann JJ Eur Urol; 2009 Jul; 56(1):113-21. PubMed ID: 18722048 [TBL] [Abstract][Full Text] [Related]
7. The role of endoscopic treatment after radical radiotherapy for invasive bladder cancer. Smith G; Quilty PM; Duncan W; Chisholm GD; Newsam JE; Hargreave TB Br J Urol; 1985 Dec; 57(6):694-9. PubMed ID: 4084728 [TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma of bladder. A review of 114 patients. Rundle JS; Hart AJ; McGeorge A; Smith JS; Malcolm AJ; Smith PM Br J Urol; 1982 Oct; 54(5):522-6. PubMed ID: 7171960 [TBL] [Abstract][Full Text] [Related]
9. [Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients]. Serretta V; Vasile P; Falletta V; Piazza F; Pavone C; Pavone-Macaluso M Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):37-40. PubMed ID: 9707769 [TBL] [Abstract][Full Text] [Related]
10. The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary? Wo JY; Shipley WU; Dahl DM; Coen JJ; Heney NM; Kaufman DS; Zietman AL BJU Int; 2009 Jul; 104(2):179-83. PubMed ID: 19154448 [TBL] [Abstract][Full Text] [Related]
11. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience. Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860 [TBL] [Abstract][Full Text] [Related]
12. Transurethral resection for muscle-invasive bladder cancer. Kondás J; Váczi L; Szecsó L; Kondér G Int Urol Nephrol; 1993; 25(6):557-63. PubMed ID: 8175277 [TBL] [Abstract][Full Text] [Related]
13. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. May M; Helke C; Nitzke T; Vogler H; Hoschke B Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349 [TBL] [Abstract][Full Text] [Related]
14. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer. Tran E; Souhami L; Tanguay S; Rajan R Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186 [TBL] [Abstract][Full Text] [Related]
16. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience. Choong NW; Quevedo JF; Kaur JS Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264 [TBL] [Abstract][Full Text] [Related]
17. T3 bladder cancer--the case for salvage cystectomy. Blandy JP; England HR; Evans SJ; Hope-Stone HF; Mair GM; Mantell BS; Oliver RT; Paris AM; Risdon RA Br J Urol; 1980 Dec; 52(6):506-10. PubMed ID: 7459580 [TBL] [Abstract][Full Text] [Related]
18. The role of partial cystectomy in the treatment of recurrent invasive bladder cancer following radiotherapy. Matthews PN; Minton MJ; Haw M; Philip PF Br J Urol; 1987 Aug; 60(2):132-5. PubMed ID: 3664203 [TBL] [Abstract][Full Text] [Related]
20. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival. Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]